SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ALECTINIB, COBIMETINIB, SATRALIZUMAB, VISMODEGIB, RISDIPLAM, OBINUTUZUMAB, EMICIZUMAB, TRASTUZUMAB SUBCUTÁNEO, TRASTUZUMAB EMTANSINA
1 Lieferant beauftragt•27 Lose vergeben•28,35 Mio. € vergeben
Auftraggeber: Servicio Murciano de Salud / Espinardo, Spain
Vergebener Wert
28,35 Mio. €
Geschätzter Wert
28,35 Mio. €
Vergeben zu 100% des geschätzten Werts
Vergabedatum
12. Feb. 2024
Gewinner
1
Vergebene Lose
27
Vergabewerte
Gesamtwert der Bekanntmachung
28,35 Mio. €
Summe der Loswerte
55,47 Mio. €
Der TED-Gesamtwert und die Werte auf Losebene stimmen nicht exakt überein.
Gewinner
RIBERA DEL LOIRA, 50, ESP
28,1 Mio. € Dieser Auftrag
27 Vergabebekanntmachungen•61 vergebene Lose•65,58 Mio. € gesamt
Vergebene Lose
| Los | Titel | Gewinner | Wert | Haupt-CPV |
|---|---|---|---|---|
| LOT-0025 | Nicht angegeben | 15,6 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | Nicht angegeben | 7,9 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | ROCHE FARMA SAU | 7,4 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | ROCHE FARMA SAU | 4,4 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | ROCHE FARMA SAU | 3,0 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | Nicht angegeben | 2,7 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | ROCHE FARMA SAU | 2,5 Mio. € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0012 | ROCHE FARMA SAU | 1,6 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0013 | ROCHE FARMA SAU | 1,4 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | ROCHE FARMA SAU | 1,3 Mio. € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | ROCHE FARMA SAU | 980.241 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | ROCHE FARMA SAU | 915.270 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0019 | Nicht angegeben | 884.112 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | ROCHE FARMA SAU | 833.464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | ROCHE FARMA SAU | 732.220 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0014 | ROCHE FARMA SAU | 624.371 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | ROCHE FARMA SAU | 606.492 € | Other nervous system medicinal products (33661700) | |
| LOT-0006 | ROCHE FARMA SAU | 436.464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0002 | ROCHE FARMA SAU | 331.782 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | ROCHE FARMA SAU | 320.345 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0020 | Nicht angegeben | 272.995 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | ROCHE FARMA SAU | 259.000 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | ROCHE FARMA SAU | 206.546 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | Nicht angegeben | 118.477 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | ROCHE FARMA SAU | 91.527 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0021 | ROCHE FARMA SAU | 52.499 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | ROCHE FARMA SAU | — | Antineoplastic and immunomodulating agents (33652000) |